QTL: GWAS2259143_H (eosinophil count QTL GWAS2259143 (human)) Homo sapiens
Symbol:
GWAS2259143_H
Name:
eosinophil count QTL GWAS2259143 (human)
RGD ID:
626445210
Trait:
eosinophil count
LOD Score:
Not Available
P Value:
3.0E-9
Variance:
Not Available
Position
Human Assembly Chr Position (strand) Source JBrowse GRCh38 9 6,197,392 - 6,197,393 RGD_MAPPER_PIPELINE GRCh38 GRCh37 9 6,197,392 - 6,197,393 RGD_MAPPER_PIPELINE GRCh37
Population Stats:
Not Available
JBrowse:
View Region in Genome Browser (JBrowse)
References
Region
Position Markers
Peak: (rs1888909 )
Human Assembly Chr Position (strand) Source GRCh38 9 6,197,392 - 6,197,393 RGD_MAPPER_PIPELINE
QTLs in Region (GRCh38)
407381705 GWAS1030681_H Nasal Cavity Polyp QTL GWAS1030681 (human) 7e-32 Nasal Cavity Polyp 9 6197392 6197393 Human 597579295 GWAS1636155_H eosinophil count QTL GWAS1636155 (human) 8e-69 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 628963068 GWAS2871297_H allergic rhinitis QTL GWAS2871297 (human) 9e-18 allergic rhinitis 9 6197392 6197393 Human 407385934 GWAS1034910_H eosinophil count QTL GWAS1034910 (human) 4e-229 eosinophil count 9 6197392 6197393 Human 597586969 GWAS1643829_H eosinophil count QTL GWAS1643829 (human) 1e-116 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 597613975 GWAS1670835_H asthma QTL GWAS1670835 (human) 5e-31 asthma 9 6197392 6197393 Human 407381954 GWAS1030930_H eosinophil count QTL GWAS1030930 (human) 3e-384 eosinophil count 9 6197392 6197393 Human 628615293 GWAS2523522_H eosinophil count QTL GWAS2523522 (human) 3e-09 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 626447197 GWAS2261130_H eosinophil count QTL GWAS2261130 (human) 7e-125 eosinophil count 9 6197392 6197393 Human 628990961 GWAS2899190_H Nasal polyposis QTL GWAS2899190 (human) 2e-28 Nasal polyposis 9 6197392 6197393 Human 597018264 GWAS1114338_H eosinophil count QTL GWAS1114338 (human) 4e-229 eosinophil count 9 6197392 6197393 Human 628996336 GWAS2904565_H asthma, family history QTL GWAS2904565 (human) 9e-13 asthma, family history 9 6197392 6197393 Human 597614477 GWAS1671337_H Nasal polyposis QTL GWAS1671337 (human) 2e-28 Nasal polyposis 9 6197392 6197393 Human 2302773 MAMTS18_H Mammary tumor susceptibility QTL 18 (human) 0.039 Mammary tumor susceptibility 9 5289149 31289149 Human 626441792 GWAS2255725_H eosinophil count QTL GWAS2255725 (human) 1e-395 eosinophil count 9 6197392 6197393 Human 2293433 PRSTS223_H Prostate tumor susceptibility QTL 223 (human) 1.6 Prostate tumor susceptibility 9 5289149 31289149 Human 616518179 GWAS1914762_H eosinophil count QTL GWAS1914762 (human) 2e-250 eosinophil count 9 6197392 6197393 Human 597584702 GWAS1641562_H asthma QTL GWAS1641562 (human) 5e-24 asthma 9 6197392 6197393 Human 407418733 GWAS1067709_H Nasal Cavity Polyp QTL GWAS1067709 (human) 1e-39 Nasal Cavity Polyp 9 6197392 6197393 Human 597587511 GWAS1644371_H eosinophil count QTL GWAS1644371 (human) 6e-69 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 628429148 GWAS2337377_H eosinophil count QTL GWAS2337377 (human) 4e-229 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 597594800 GWAS1651660_H eosinophil count QTL GWAS1651660 (human) 7e-168 eosinophil count 9 6197392 6197393 Human 628738632 GWAS2646861_H eosinophil count QTL GWAS2646861 (human) 9e-154 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 407053302 GWAS702278_H eosinophil percentage of leukocytes QTL GWAS702278 (human) 4e-255 eosinophil percentage of leukocytes 9 6197392 6197393 Human 628983364 GWAS2891593_H eosinophil count QTL GWAS2891593 (human) 4e-143 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 2293400 PRSTS224_H Prostate tumor susceptibility QTL 224 (human) 1.62 Prostate tumor susceptibility 9 5289149 31289149 Human 407384946 GWAS1033922_H eosinophil count QTL GWAS1033922 (human) 1e-395 eosinophil count 9 6197392 6197393 Human 407386738 GWAS1035714_H chronic rhinosinusitis QTL GWAS1035714 (human) 0.0000006 chronic rhinosinusitis 9 6197392 6197393 Human 628550988 GWAS2459217_H level of bone marrow proteoglycan in blood QTL GWAS2459217 (human) 3e-13 level of bone marrow proteoglycan in blood 9 6197392 6197393 Human 597584933 GWAS1641793_H eosinophil count QTL GWAS1641793 (human) 2e-126 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 628814904 GWAS2723133_H eosinophil count QTL GWAS2723133 (human) 2e-250 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 597373023 GWAS1469097_H chronic rhinosinusitis QTL GWAS1469097 (human) 0.0000006 chronic rhinosinusitis 9 6197392 6197393 Human 617203842 GWAS2184282_H level of bone marrow proteoglycan in blood QTL GWAS2184282 (human) 3e-13 level of bone marrow proteoglycan in blood 9 6197392 6197393 Human 597613394 GWAS1670254_H asthma, family history QTL GWAS1670254 (human) 9e-13 asthma, family history 9 6197392 6197393 Human 626445210 GWAS2259143_H eosinophil count QTL GWAS2259143 (human) 3e-09 eosinophil count 9 6197392 6197393 Human 597018203 GWAS1114277_H eosinophil count QTL GWAS1114277 (human) 3e-384 eosinophil count 9 6197392 6197393 Human 597364810 GWAS1460884_H eosinophil percentage of leukocytes QTL GWAS1460884 (human) 4e-255 eosinophil percentage of leukocytes 9 6197392 6197393 Human 597594826 GWAS1651686_H eosinophil count QTL GWAS1651686 (human) 3e-207 eosinophil count 9 6197392 6197393 Human 597584586 GWAS1641446_H drug use measurement, asthma QTL GWAS1641446 (human) 5e-13 drug use measurement, asthma 9 6197392 6197393 Human 628988971 GWAS2897200_H asthma QTL GWAS2897200 (human) 5e-31 asthma 9 6197392 6197393 Human 597444555 GWAS1540629_H eosinophil count QTL GWAS1540629 (human) 3e-09 eosinophil count 9 6197392 6197393 Human 628983338 GWAS2891567_H eosinophil count QTL GWAS2891567 (human) 3e-207 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 2315898 GLUCO191_H Glucose level QTL 191 (human) 1.83 Glucose level 9 5289149 31289149 Human 407417746 GWAS1066722_H eosinophil count QTL GWAS1066722 (human) 3e-09 eosinophil count 9 6197392 6197393 Human 616506077 GWAS1902660_H level of bone marrow proteoglycan in blood serum QTL GWAS1902660 (human) 3e-13 level of bone marrow proteoglycan in blood serum 9 6197392 6197393 Human 407404843 GWAS1053819_H eosinophil count QTL GWAS1053819 (human) 9e-154 eosinophil count 9 6197392 6197393 Human 1357299 AASTH47_H Allergic/atopic asthma related QTL 47 (human) 0.00028 Reversible airflow obstruction 9 5289149 31289149 Human 597596276 GWAS1653136_H eosinophil count QTL GWAS1653136 (human) 4e-143 eosinophil count 9 6197392 6197393 Human 628607004 GWAS2515233_H Nasal Cavity Polyp QTL GWAS2515233 (human) 1e-39 Nasal Cavity Polyp 9 6197392 6197393 Human 407398564 GWAS1047540_H eosinophil count QTL GWAS1047540 (human) 7e-125 eosinophil count 9 6197392 6197393 Human 628427291 GWAS2335520_H eosinophil count QTL GWAS2335520 (human) 1e-395 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 626443065 GWAS2256998_H eosinophil count QTL GWAS2256998 (human) 9e-154 eosinophil count 9 6197392 6197393 Human 597435372 GWAS1531446_H Nasal Cavity Polyp QTL GWAS1531446 (human) 1e-39 Nasal Cavity Polyp 9 6197392 6197393 Human 597393385 GWAS1489459_H eosinophil count QTL GWAS1489459 (human) 1e-395 eosinophil count 9 6197392 6197393 Human 626444068 GWAS2258001_H eosinophil count QTL GWAS2258001 (human) 4e-229 eosinophil count 9 6197392 6197393 Human 628982031 GWAS2890260_H eosinophil count QTL GWAS2890260 (human) 7e-168 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 597423080 GWAS1519154_H eosinophil count QTL GWAS1519154 (human) 9e-154 eosinophil count 9 6197392 6197393 Human 628429958 GWAS2338187_H eosinophil count QTL GWAS2338187 (human) 3e-384 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 1643245 BW137_H Body weight QTL 137 (human) 2.28 Body weight 9 5289149 31289149 Human 597590891 GWAS1647751_H allergic rhinitis QTL GWAS1647751 (human) 9e-18 allergic rhinitis 9 6197392 6197393 Human 597507562 GWAS1603636_H eosinophil count QTL GWAS1603636 (human) 7e-125 eosinophil count 9 6197392 6197393 Human 597373027 GWAS1469101_H Nasal Cavity Polyp QTL GWAS1469101 (human) 7e-32 Nasal Cavity Polyp 9 6197392 6197393 Human 626444717 GWAS2258650_H eosinophil count QTL GWAS2258650 (human) 3e-384 eosinophil count 9 6197392 6197393 Human 597586402 GWAS1643262_H eosinophil count QTL GWAS1643262 (human) 3e-130 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 628441609 GWAS2349838_H eosinophil percentage of leukocytes QTL GWAS2349838 (human) 4e-255 eosinophil quantity (VT:0002602) blood eosinophil count to total leukocyte count ratio (CMO:0000369) 9 6197392 6197393 Human 628891777 GWAS2800006_H eosinophil count QTL GWAS2800006 (human) 7e-125 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human 597588192 GWAS1645052_H eosinophil count QTL GWAS1645052 (human) 1e-147 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 9 6197392 6197393 Human
Additional Information
GWAS QTLs Related by Peak Marker
Data has come from the GWAS Catalog
The highlighted row represents the current QTL
QTL
GWAS Catalog Study
Disease Trait
Study Size
Risk Allele
Risk Allele Frequency
P Value
P Value MLOG
Peak Marker
Reported Odds Ratio or Beta-coefficient
Ontology Accession
PubMed
GWAS1636155_H
GCST90479606
eosinophil (fraction, minimum, inv-norm transformed)
98,055 African American or Afro-Caribbean individuals, 47,410 Hispanic or Latin American individuals, 4,652 East Asian ancestry individuals, 335,542 European ancestry individuals
T
0.3136
8E-69
68.097
rs1888909
0.05199
eosinophil count (EFO:0004842)
PMID:39024449
GWAS1641446_H
GCST90479584
Takes medication for asthma?
4,269 African American or Afro-Caribbean cases, 51,236 African American or Afro-Caribbean controls, 2,023 Hispanic or Latin American cases, 27,291 Hispanic or Latin American controls, 263 East Asian ancestry cases, 3,284 East Asian ancestry controls, 18,629 European ancestry cases, 297,039 European ancestry controls
T
0.2998
5E-13
12.302
rs1888909
0.07927
drug use measurement (EFO:0007010)
PMID:39024449
GWAS1641562_H
GCST90479585
Asthma
5,678 African American or Afro-Caribbean cases, 49,827 African American or Afro-Caribbean controls, 2,887 Hispanic or Latin American cases, 26,427 Hispanic or Latin American controls, 388 East Asian ancestry cases, 3,159 East Asian ancestry controls, 26,657 European ancestry cases, 289,011 European ancestry controls
T
0.2998
5E-24
23.302
rs1888909
0.09777
PMID:39024449
GWAS1641793_H
GCST90479602
eosinophil (absolute count, mean, inv-norm transformed)
90,448 African American or Afro-Caribbean individuals, 42,397 Hispanic or Latin American individuals, 3,996 East Asian ancestry individuals, 310,757 European ancestry individuals
T
0.3144
2E-126
125.699
rs1888909
0.08301
eosinophil count (EFO:0004842)
PMID:39024449
GWAS1643262_H
GCST90479604
eosinophil (fraction, maximum, inv-norm transformed)
98,055 African American or Afro-Caribbean individuals, 47,410 Hispanic or Latin American individuals, 4,652 East Asian ancestry individuals, 335,542 European ancestry individuals
T
0.3136
3E-130
129.523
rs1888909
0.07953
eosinophil count (EFO:0004842)
PMID:39024449
GWAS1643829_H
GCST90479601
eosinophil (absolute count, maximum, inv-norm transformed)
90,403 African American or Afro-Caribbean individuals, 42,380 Hispanic or Latin American individuals, 3,995 East Asian ancestry individuals, 310,588 European ancestry individuals
T
0.3144
1E-116
116
rs1888909
0.07738
eosinophil count (EFO:0004842)
PMID:39024449
GWAS1644371_H
GCST90479603
eosinophil (absolute count, minimum, inv-norm transformed)
90,479 African American or Afro-Caribbean individuals, 42,403 Hispanic or Latin American individuals, 3,997 East Asian ancestry individuals, 310,849 European ancestry individuals
T
0.3144
6E-69
68.222
rs1888909
0.05105
eosinophil count (EFO:0004842)
PMID:39024449
GWAS1645052_H
GCST90479605
eosinophil (fraction, mean, inv-norm transformed)
98,055 African American or Afro-Caribbean individuals, 47,410 Hispanic or Latin American individuals, 4,652 East Asian ancestry individuals, 335,542 European ancestry individuals
T
0.3136
1E-147
147
rs1888909
0.08835
eosinophil count (EFO:0004842)
PMID:39024449
GWAS2335520_H
GCST90002302
Eosinophil count
583,850 African American or Afro-Caribbean, African ancestry, European ancestry, East Asian ancestry, Hispanic or Latin American and South Asian ancestry individuals
C
0.773068
1E-395
395
rs1888909
N/A
eosinophil count (EFO:0004842)
PMID:32888493
GWAS2337377_H
GCST90002381
Eosinophil count
408,112 British individuals
C
0.744314
4E-229
228.398
rs1888909
0.08715122
eosinophil count (EFO:0004842)
PMID:32888494
GWAS2338187_H
GCST90002298
Eosinophil count
474,237 European ancestry individuals
C
0.744354
3E-384
383.523
rs1888909
0.095262
eosinophil count (EFO:0004842)
PMID:32888493
GWAS2349838_H
GCST90002382
Eosinophil percentage of white cells
408,112 British individuals
C
0.744298
4E-255
254.398
rs1888909
0.08975637
eosinophil percentage of leukocytes (EFO:0007991)
PMID:32888494
GWAS2459217_H
GCST90470322
PRG2 protein levels
47,745 European ancestry individuals
C
0.7474701
3E-13
12.523
rs1888909
0.04290099
level of bone marrow proteoglycan in blood (OBA:2050844)
PMID:39789286
GWAS2515233_H
GCST90018883
Nasal polyps
5,093 European ancestry cases, 444,966 European ancestry controls, 160 East Asian ancestry cases, 151,846 East Asian ancestry controls
C
NR
1E-39
39
rs1888909
0.3161
Nasal Cavity Polyp (EFO:1000391)
PMID:34594039
GWAS2523522_H
GCST90018733
Eosinophil count
93,063 East Asian ancestry individuals
C
0.969523
3E-9
8.523
rs1888909
0.0762913
eosinophil count (EFO:0004842)
PMID:34594039
GWAS2646861_H
GCST90056180
Eosinophil count
234,763 European ancestry individuals
T
0.256
9E-154
153.046
rs1888909
N/A
eosinophil count (EFO:0004842)
PMID:34469753
GWAS1469097_H
GCST007444
Chronic rhinosinusitis
251 European ancestry whole-genome sequenced cases, 5,357 European ancestry cases, 13,957 European ancestry whole-genome sequenced controls, 746,129 European ancestry controls
T
0.253
6E-7
6.222
rs1888909
1.12
chronic rhinosinusitis (EFO:1000024)
PMID:30643255
GWAS1469101_H
GCST007443
Nasal polyps
86 European ancestry whole-genome sequenced cases, 4,280 European ancestry cases, 13,941 European ancestry whole-genome sequenced controls, 700,740 European ancestry controls
T
0.253
7E-32
31.155
rs1888909
1.34
Nasal Cavity Polyp (EFO:1000391)
PMID:30643255
GWAS2723133_H
GCST90468068
Eosinophill count (UKB data field 30150)
394,642 European ancestry individuals
C
0.74465466
2E-250
249.699
rs1888909
0.076284416
eosinophil count (EFO:0004842)
PMID:39789286
GWAS2800006_H
GCST90134621
Eosinophil count
365,954 British ancestry individuals
T
0.26
7E-125
124.155
rs1888909
0.1
eosinophil count (EFO:0004842)
PMID:35935937
GWAS2871297_H
GCST90476021
Allergic rhinitis (PheCode 476)
92,310 European ancestry cases, 311,377 European ancestry controls
T
0.2744
9E-18
17.046
rs1888909
0.05207
allergic rhinitis (EFO:0005854)
PMID:39024449
GWAS2890260_H
GCST90475297
eosinophil (fraction, maximum, inv-norm transformed)
335,542 European ancestry individuals
T
0.2749
7E-168
167.155
rs1888909
0.09279
eosinophil count (EFO:0004842)
PMID:39024449
GWAS2891567_H
GCST90475300
eosinophil (fraction, mean, inv-norm transformed)
335,542 European ancestry individuals
T
0.2749
3E-207
206.523
rs1888909
0.106
eosinophil count (EFO:0004842)
PMID:39024449
GWAS2891593_H
GCST90475288
eosinophil (absolute count, maximum, inv-norm transformed)
310,588 European ancestry individuals
T
0.2752
4E-143
142.398
rs1888909
0.08919
eosinophil count (EFO:0004842)
PMID:39024449
GWAS2897200_H
GCST90480249
Asthma
12,093 African American or Afro-Caribbean cases, 105,134 African American or Afro-Caribbean controls, 5,688 Hispanic or Latin American cases, 52,071 Hispanic or Latin American controls, 609 East Asian ancestry cases, 6,004 East Asian ancestry controls, 36,823 European ancestry cases, 398,278 European ancestry controls
T
0.3106
5E-31
30.302
rs1888909
0.08906
PMID:39024449
GWAS2899190_H
GCST90480233
Nasal polyps (PheCode 471)
905 African American or Afro-Caribbean cases, 120,199 African American or Afro-Caribbean controls, 4,037 European ancestry cases, 444,004 European ancestry controls, 452 Hispanic or Latin American cases, 59,080 Hispanic or Latin American controls
T
0.3131
2E-28
27.699
rs1888909
0.2467
Nasal polyposis (HP:0100582)
PMID:39024449
GWAS2904565_H
GCST90480683
Biological Sibling: Asthma
5,022 African American or Afro-Caribbean cases, 50,483 African American or Afro-Caribbean controls, 2,302 Hispanic or Latin American cases, 27,012 Hispanic or Latin American controls, 313 East Asian ancestry cases, 3,234 East Asian ancestry controls, 18,209 European ancestry cases, 297,459 European ancestry controls
T
0.2998
9E-13
12.046
rs1888909
0.07644
family history (EFO:0000493)
PMID:39024449
External Database Links
Database
Acc Id
Source(s)
GWAS Catalog
GCST90018733
GWAS Catalog